Edition:
United Kingdom

Healthcare Headlines

Icahn reverses position on Cigna-Express Scripts deal

Activist investor Carl Icahn said on Monday that he no longer intended to solicit proxies to vote against the $52 billion Cigna-Express Scripts deal, a turn around from his position last week when he urged the health insurer's shareholders to vote against it.

Advisory firm ISS backs Cigna's Express Scripts buy

Shareholder advisory firm Institutional Shareholder Services Inc (ISS) on Friday recommended that Cigna Corp investors vote for the health insurer's $52 billion purchase of pharmacy benefits manager Express Scripts , a deal that has been opposed by activist investor Carl Icahn.

UnitedHealth is buying pharmacy operator Genoa: Axios

Health insurer UnitedHealth Group Inc has at least a tentative agreement to buy specialty pharmacy operator Genoa Health from private equity firm Advent International, news website Axios reported, citing a source familiar with the deal.

American Medical Association opposes merger of CVS and Aetna

The American Medical Association, which represents U.S. physicians, urged the U.S. Justice Department on Wednesday to stop CVS Health Corp's plan to buy insurance provider Aetna Inc, saying the deal could result in higher prices for prescription medicines.

Icahn to send letter to oppose Cigna-Express Scripts deal: WSJ

Investor Carl Icahn will send an open letter to the shareholders of insurer Cigna Corp asking them to vote against the company's $52 billion Express Scripts Holding Co buyout, the Wall Street Journal reported on Monday, citing a draft of the letter.

Icahn, with sizable stake in Cigna, to oppose Express Scripts acquisition: WSJ

Billionaire investor Carl Icahn has a sizable stake in health insurer Cigna and plans to vote against its planned $52 billion acquisition of pharmacy benefits manager Express Scripts , the Wall Street Journal reported https://www.wsj.com/articles/carl-icahn-has-sizable-stake-in-cigna-plans-to-vote-against-express-scripts-deal-1533150217 on Wednesday.